ArticleEuropean journal of medical research2025
Association between dietary theobromine and age-related macular degeneration: results from NHANES 2005-2008 and in vitro experiments.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the relationship between theobromine and age-related macular degeneration (AMD) using a nationwide representative sample of adults and in vitro experiments.
methodsWe analyzed data from the 2005-2008 years of the National Health and Nutrition Examination Survey (NHANES), which included 5485 participants with available data on dietary theobromine intake and AMD. Multivariable logistic regression and smoothing curve fitting were used to examine the potential correlations. The inflection point was determined using a two-piecewise linear regression. Interaction tests and subgroup analyses were also conducted. In vitro experiments were conducted to investigate the effects of theobromine on cell proliferation, intracellular reactive oxygen species (ROS) levels, and the expression of heme oxygenase-1 (HO-1) and superoxide dismutase-1 (SOD-1) in a sodium iodate (NaIO
resultsAfter controlling for potential confounding variables, the multivariate logistic regression model revealed an odds ratio of 0.73 (95% confidence interval: 0.56-0.98) for the association between dietary theobromine and AMD. The usage of smoothing curve fitting revealed a non-linear relationship, with an inflection point observed at 60 mg/d (adjust OR 0.31;95% CI 0.14-0.66). The negative correlation remained consistent across various demographic scenarios in subgroup analyses and interaction tests. In the NaIO
conclusionsA non-linear negative correlation between dietary theobromine and AMD was observed, and the antioxidant activity of theobromine was observed in vitro. Our findings suggest a potential association between higher theobromine intake and lower odds of AMD prevalence, which warrants further investigation of its therapeutic implications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.